InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

Current share price for IMR : $1.850 0.055 (3.06%)+

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$663 Ceasing to be a substantial holder 22 Jun 2022 4:53PM $0.125 $1.850 risen by 1,380%
$663 Change in substantial holding 22 Jun 2022 8:22AM $0.115 $1.850 risen by 1,508.70%
$663 Appendix 3Y - SW 21 Jun 2022 9:24AM $0.115 $1.850 risen by 1,508.70%
$663 Notification of cessation of securities - IMR 21 Jun 2022 9:20AM $0.115 $1.850 risen by 1,508.70%
$663 Notification regarding unquoted securities - IMR 21 Jun 2022 9:17AM $0.115 $1.850 risen by 1,508.70%
$663 Application for quotation of securities - IMR 21 Jun 2022 9:11AM $0.115 $1.850 risen by 1,508.70%
$663 Change in substantial holding 17 Jun 2022 8:19AM $0.150 $1.850 risen by 1,133.33%
$663 Change of Director's Interest Notice 16 Jun 2022 12:59PM $0.130 $1.850 risen by 1,323.08%
$663 Change of Director's Interest Notice 9 Jun 2022 9:59AM $0.200 $1.850 risen by 825%
$663 Change in substantial holding 7 Jun 2022 5:07PM $0.205 $1.850 risen by 802.44%
$663 Results of Meeting 4 May 2022 2:48PM $0.430 $1.850 risen by 330.23%
$663 Notification of cessation of securities - IMR 4 May 2022 9:34AM $0.470 $1.850 risen by 293.62%
$663 Annual Stockholder Meeting Presentation Slides 4 May 2022 8:43AM $0.470 $1.850 risen by 293.62%
$663 Annual Meeting Of Stockholders Chair's Address 4 May 2022 8:39AM $0.470 $1.850 risen by 293.62%
$663 NWR Virtual Conference Presentation 2 May 2022 9:28AM $0.490 $1.850 risen by 277.55%
$663 Imricor to Present at NWR Virtual Conference 29 Apr 2022 8:59AM $0.490 $1.850 risen by 277.55%
$663 Appendix 4C - Quarterly Report and Business Update 28 Apr 2022 9:14AM $0.480 $1.850 risen by 285.42%
$663 Updated Corporate Goverance Statement 28 Apr 2022 9:01AM $0.480 $1.850 risen by 285.42%
$663 Letter to Shareholders and Online Meeting Guide 8 Apr 2022 10:36AM $0.625 $1.850 risen by 196%
$663 Notice of Annual Stockholders Meeting and CDI Voting Form 8 Apr 2022 10:35AM $0.625 $1.850 risen by 196%
$663 Appendix 4G and Corporate Governance Statement 8 Apr 2022 10:34AM $0.625 $1.850 risen by 196%
$663 Annual Report to shareholders 8 Apr 2022 10:33AM $0.625 $1.850 risen by 196%
$663 Imricor Adds 15th Site and First in Italy 1 Apr 2022 9:47AM $0.650 $1.850 risen by 184.62%
$663 Change of Director's Interest Notice 28 Mar 2022 9:14AM $0.690 $1.850 risen by 168.12%
$663 S&P DJI Announces March 2022 Quarterly Rebalance 4 Mar 2022 5:02PM $0.515 $1.850 risen by 259.22%

376 - 400 of 602 results

Page 16 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.